New combo therapy targets Hard-to-Treat breast cancer
NCT ID NCT06726148
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This study tests a new drug called ECI830, alone or with other cancer drugs, in people with advanced hormone receptor-positive, HER2-negative breast cancer or certain solid tumors. The goal is to find safe doses and see if the combination shrinks tumors or delays growth. About 280 adults who have already tried other treatments will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HR+/HER2- BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02115, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Florida Cancer Specialists
RECRUITINGFort Myers, Florida, 33901, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fred Hutch Cancer Research
RECRUITINGSeattle, Washington, 98109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
MD Anderson Cancer Center Uni of Te
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Memorial Sloan Kettering
RECRUITINGNew York, New York, 10017, United States
Contact Email: •••••@•••••
Contact
-
Novartis Investigative Site
RECRUITINGClayton, Victoria, 3168, Australia
-
Novartis Investigative Site
RECRUITINGMelbourne, Victoria, 3004, Australia
-
Novartis Investigative Site
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Novartis Investigative Site
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
Novartis Investigative Site
RECRUITINGNanjing, Jiangsu, 210029, China
-
Novartis Investigative Site
RECRUITINGXian, Shanxi, 710061, China
-
Novartis Investigative Site
RECRUITINGBrno, 656 53, Czechia
-
Novartis Investigative Site
RECRUITINGCopenhagen, DK-2100, Denmark
-
Novartis Investigative Site
RECRUITINGOdense C, 5000, Denmark
-
Novartis Investigative Site
RECRUITINGBordeaux, 33076, France
-
Novartis Investigative Site
RECRUITINGSaint-Herblain, 44805, France
-
Novartis Investigative Site
RECRUITINGFreiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
-
Novartis Investigative Site
RECRUITINGHeidelberg, 69120, Germany
-
Novartis Investigative Site
RECRUITINGUlm, 89081, Germany
-
Novartis Investigative Site
RECRUITINGHaifa, 3109601, Israel
-
Novartis Investigative Site
RECRUITINGTel Aviv, 6423906, Israel
-
Novartis Investigative Site
RECRUITINGModena, MO, 41124, Italy
-
Novartis Investigative Site
RECRUITINGMilan, 20141, Italy
-
Novartis Investigative Site
RECRUITINGChuo Ku, Tokyo, 1040045, Japan
-
Novartis Investigative Site
RECRUITINGSingapore, 119074, Singapore
-
Novartis Investigative Site
RECRUITINGSeoul, 03080, South Korea
-
Novartis Investigative Site
RECRUITINGBarcelona, 08035, Spain
-
Novartis Investigative Site
RECRUITINGBarcelona, 08036, Spain
-
Novartis Investigative Site
RECRUITINGTainan, 704, Taiwan
-
Novartis Investigative Site
RECRUITINGLondon, Oxford, OX3 7LE, United Kingdom
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
Contact
Contact Email: •••••@•••••
-
University of California LA
RECRUITINGLos Angeles, California, 90095, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
WA Uni School Of Med
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.